.png)
Occupational Medicines Market by Applicationand End User- Global Industry Analysis & Forecast to 2027
Published On : September 2020 Pages : 152 Category: Pharma & Healthcare Report Code : HC0912867
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Occupational Medicines MarketBy Application(Chronic respiratory disease, Chemical poisoning, Musculoskeletal disorder, Chemical poisoning, Cancer, Non-Induced hearing loss & vibration, Pneumoconiosis, Skin disorder and Others)and End User(Manufacturing, Agriculture & forestry, Transportation, Construction, Petroleum & mining and Others)- Global Industry Analysis And Forecast To 2027
Industry Outlook
Occupational Medicines is also called asoccupational health and it is focused on the diagnostics and treatment of illness of injuries that are related to work. Specially trained physicians in this field can treat and diagnose the injuries related to work than the general physician. These medicines are necessary for the treatment of various illness and injuries arising due to work in hazardous environment. Therefore, the Occupational Medicines Marketis anticipated to expand and has tremendous scope during the forecast period. The global Occupational Medicines Marketanticipated to flourish in the future by growing at a significantly higher CAGR.
Drivers and Restraints
Occupational Medicines sees growth in the future due to factors like, rising awareness regarding the occupational health, rise in the aging workforce in various industries, rise in the number of small scale business across the globe and various other factors.
Regional Insights
Occupational Medicinesshows growth in the Asia-Pacific region due to rise in R&D activities, increasing disposable income with the people, rise in awareness regarding disease diagnosis and some other factors.
Occupational Medicines Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Johnson & Johnson
- Amgen Inc.
- Novartis AG
- AstraZeneca PLC
- Sanofi
- Bristol-Myers Squibb Company
- Pfizer Inc.
- Eli Lilly and Company
- Nestlé S.A. (Galderma S.A.)
- F. Hoffmann-La Roche Ltd.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Occupational Medicines Market Classification
o Occupational Medicines Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Chronic respiratory disease
o Chemical poisoning
o Musculoskeletal disorder
o Chemical poisoning
o Cancer
o Non-Induced hearing loss & vibration
o Pneumoconiosis
o Skin disorder
o Others
o Occupational Medicines Market, ByEnd User, Estimates and Forecast, 2017-2027 ($Million)
o Manufacturing
o Agriculture & forestry
o Transportation
o Construction
o Petroleum & mining
o Others
o Occupational Medicines Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Johnson & Johnson
o Amgen Inc.
o Novartis AG
o AstraZeneca PLC
o Sanofi
o Bristol-Myers Squibb Company
o Pfizer Inc.
o Eli Lilly and Company
o Nestlé S.A. (Galderma S.A.)
o F. Hoffmann-La Roche Ltd.
o Occupational Medicines Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Occupational Medicines Market, By Country
o U.S. Occupational Medicines Market
o Canada Occupational Medicines Market
o Mexico Occupational Medicines Market
o Europe
§ Europe Occupational Medicines Market, By Country
o Germany Occupational Medicines Market
o UK Occupational Medicines Market
o France Occupational Medicines Market
o Russia Occupational Medicines Market
o Italy Occupational Medicines Market
o Rest of Europe Occupational Medicines Market
o Asia-Pacific
§ Asia-Pacific Occupational Medicines Market, By Country
o China Occupational Medicines Market
o Japan Occupational Medicines Market
o South Korea Occupational Medicines Market
o India Occupational Medicines Market
o Southeast Asia Occupational Medicines Market
o Rest of Asia-Pacific Occupational Medicines Market
o South America
§ South America Occupational Medicines Market, By Country
o Brazil Occupational Medicines Market
o Argentina Occupational Medicines Market
o Columbia Occupational Medicines Market
o Rest of South America Occupational Medicines Market
o Middle East and Africa
§ Middle East and Africa Occupational Medicines Market, By Country
o Saudi Arabia Occupational Medicines Market
o UAE Occupational Medicines Market
o Egypt Occupational Medicines Market
o Nigeria Occupational Medicines Market
o South Africa Occupational Medicines Market
o Rest of MEA Occupational Medicines Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Market Dashboard
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Occupational Medicines Market, By Application
5.1. Introduction
5.2. Global Occupational Medicines Revenue and Market Share by Application (2017-2021)
5.2.1. Global Occupational Medicines Revenue and Revenue Share by Application (2017-2021)
5.3. Chronic respiratory disease
5.3.1. Global Chronic respiratory disease Revenue and Growth Rate (2017-2021)
5.4. Chemical poisoning
5.4.1. Global Chemical poisoning Revenue and Growth Rate (2017-2021)
5.5. Musculoskeletal disorder
5.5.1. Global Musculoskeletal disorder Revenue and Growth Rate (2017-2021)
5.6. Chemical poisoning
5.6.1. Global Chemical poisoning Revenue and Growth Rate (2017-2021)
5.7. Cancer
5.7.1. Global Cancer Revenue and Growth Rate (2017-2021)
5.8. Non-Induced hearing loss & vibration
5.8.1. Global Non-Induced hearing loss & vibration Revenue and Growth Rate (2017-2021)
5.9. Pneumoconiosis
5.9.1. Global Pneumoconiosis Revenue and Growth Rate (2017-2021)
5.10. Skin disorder
5.10.1. Global Skin disorder Revenue and Growth Rate (2017-2021)
5.11. Others
5.11.1. Global Others Revenue and Growth Rate (2017-2021)
6. Occupational Medicines Market, By End User
6.1. Introduction
6.2. Global Occupational Medicines Revenue and Market Share by End User (2017-2021)
6.2.1. Global Occupational Medicines Revenue and Revenue Share by End User (2017-2021)
6.3. Manufacturing
6.3.1. Global Manufacturing Revenue and Growth Rate (2017-2021)
6.4. Agriculture & forestry
6.4.1. Global Agriculture & forestry Revenue and Growth Rate (2017-2021)
6.5. Transportation
6.5.1. Global Transportation Revenue and Growth Rate (2017-2021)
6.6. Construction
6.6.1. Global Construction Revenue and Growth Rate (2017-2021)
6.7. Petroleum & mining
6.7.1. Global Petroleum & mining Revenue and Growth Rate (2017-2021)
6.8. Others
6.8.1. Global Others Revenue and Growth Rate (2017-2021)
7. Occupational Medicines Market, By Region
7.1. Introduction
7.2. Global Occupational Medicines Revenue and Market Share by Regions
7.2.1. Global Occupational Medicines Revenue by Regions (2017-2021)
7.3. North America Occupational Medicines by Countries
7.3.1. North America Occupational Medicines Revenue and Growth Rate (2017-2021)
7.3.2. North America Occupational Medicines Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Occupational Medicines by Countries
7.4.1. Europe Occupational Medicines Revenue and Growth Rate (2017-2021)
7.4.2. Europe Occupational Medicines Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Occupational Medicines by Countries
7.5.1. Asia-Pacific Occupational Medicines Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Occupational Medicines Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Occupational Medicines by Countries
7.6.1. South America Occupational Medicines Revenue and Growth Rate (2017-2021)
7.6.2. South America Occupational Medicines Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Occupational Medicines by Countries
7.7.1. Middle East and Africa Occupational Medicines Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Occupational Medicines Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Johnson & Johnson
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Amgen Inc.
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Novartis AG
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. AstraZeneca PLC
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Sanofi
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Bristol-Myers Squibb Company
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Pfizer Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Eli Lilly and Company
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Nestlé S.A. (Galderma S.A.)
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. F. Hoffmann-La Roche Ltd.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Occupational Medicines Market Forecast (2022-2027)
9.1. Global Occupational Medicines Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Occupational Medicines Market Forecast by Regions (2022-2027)
9.2.1. North America Occupational Medicines Market Forecast (2022-2027)
9.2.1.1. United States Occupational Medicines Market Forecast (2022-2027)
9.2.1.2. Canada Occupational Medicines Market Forecast (2022-2027)
9.2.1.3. Mexico Occupational Medicines Market Forecast (2022-2027)
9.2.2. Europe Occupational Medicines Market Forecast (2022-2027)
9.2.2.1. Germany Occupational Medicines Market Forecast (2022-2027)
9.2.2.2. France Occupational Medicines Market Forecast (2022-2027)
9.2.2.3. UK Occupational Medicines Market Forecast (2022-2027)
9.2.2.4. Russia Occupational Medicines Market Forecast (2022-2027)
9.2.2.5. Italy Occupational Medicines Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Occupational Medicines Market Forecast (2022-2027)
9.2.3. Asia-Pacific Occupational Medicines Market Forecast (2022-2027)
9.2.3.1. China Occupational Medicines Market Forecast (2022-2027)
9.2.3.2. Japan Occupational Medicines Market Forecast (2022-2027)
9.2.3.3. Korea Occupational Medicines Market Forecast (2022-2027)
9.2.3.4. India Occupational Medicines Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Occupational Medicines Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Occupational Medicines Market Forecast (2022-2027)
9.2.4. South America Occupational Medicines Market Forecast (2022-2027)
9.2.4.1. Brazil Occupational Medicines Market Forecast (2022-2027)
9.2.4.2. Argentina Occupational Medicines Market Forecast (2022-2027)
9.2.4.3. Columbia Occupational Medicines Market Forecast (2022-2027)
9.2.4.4. Rest of South America Occupational Medicines Market Forecast (2022-2027)
9.2.5. Middle East and Africa Occupational Medicines Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Occupational Medicines Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Occupational Medicines Market Forecast (2022-2027)
9.2.5.3. Egypt Occupational Medicines Market Forecast (2022-2027)
9.2.5.4. Nigeria Occupational Medicines Market Forecast (2022-2027)
9.2.5.5. South Africa Occupational Medicines Market Forecast (2022-2027)
9.2.5.6. Turkey Occupational Medicines Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Occupational Medicines Market Forecast (2022-2027)
9.3. Occupational Medicines Market Forecast by Application (2022-2027)
9.3.1. Occupational Medicines Forecast by Application (2022-2027)
9.3.2. Occupational Medicines Market Share Forecast by Application (2022-2027)
9.4. Occupational Medicines Market Forecast by End User (2022-2027)
9.4.1. Occupational Medicines Forecast by End User (2022-2027)
9.4.2. Occupational Medicines Market Share Forecast by End User (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Occupational Medicines Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Occupational Medicines Revenue and Revenue Share by Application (2017-2019)
Figure Global Chronic respiratory disease Revenue and Growth Rate (2017-2019)
Figure Global Chemical poisoning Revenue and Growth Rate (2017-2019)
Figure Global Musculoskeletal disorder Revenue and Growth Rate (2017-2019)
Figure Global Chemical poisoning Revenue and Growth Rate (2017-2019)
Figure Global Cancer Revenue and Growth Rate (2017-2019)
Figure Global Non-Induced hearing loss & vibration Revenue and Growth Rate (2017-2019)
Figure Global Pneumoconiosis Revenue and Growth Rate (2017-2019)
Figure Global Skin disorder Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Occupational Medicines Revenue and Revenue Share by End User (2017-2019)
Figure Global Manufacturing Revenue and Growth Rate (2017-2019)
Figure Global Agriculture & forestry Revenue and Growth Rate (2017-2019)
Figure Global Transportation Revenue and Growth Rate (2017-2019)
Figure Global Construction Revenue and Growth Rate (2017-2019)
Figure Global Petroleum & mining Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Occupational Medicines Revenue by Regions (2017-2019)
Figure North America Occupational Medicines Growth Rate (2017-2019)
Figure North America Occupational Medicines Revenue and Growth Rate (2017-2019)
Figure North America Occupational Medicines by Countries (2017-2019)
Figure North America Occupational Medicines Revenue (Million USD) by Countries (2017-2019)
Figure United States Occupational Medicines Growth Rate (2017-2019)
Figure United States Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Occupational Medicines Growth Rate (2017-2019)
Figure Canada Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Occupational Medicines Growth Rate (2017-2019)
Figure Mexico Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Occupational Medicines Growth Rate (2017-2019)
Figure Europe Occupational Medicines Revenue and Growth Rate (2017-2019)
Figure Europe Occupational Medicines by Countries (2017-2019)
Figure Europe Occupational Medicines Revenue (Million USD) by Countries (2017-2019)
Figure Germany Occupational Medicines Growth Rate (2017-2019)
Figure Germany Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Occupational Medicines Growth Rate (2017-2019)
Figure France Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Occupational Medicines Growth Rate (2017-2019)
Figure UK Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Occupational Medicines Growth Rate (2017-2019)
Figure Russia Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Occupational Medicines Growth Rate (2017-2019)
Figure Italy Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Occupational Medicines Growth Rate (2017-2019)
Figure Rest of Europe Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Occupational Medicines Growth Rate (2017-2019)
Figure Asia-Pacific Occupational Medicines Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Occupational Medicines by Countries (2017-2019)
Figure Asia-Pacific Occupational Medicines Revenue (Million USD) by Countries (2017-2019)
Figure China Occupational Medicines Growth Rate (2017-2019)
Figure China Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Occupational Medicines Growth Rate (2017-2019)
Figure Japan Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Occupational Medicines Growth Rate (2017-2019)
Figure Korea Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Occupational Medicines Growth Rate (2017-2019)
Figure India Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Occupational Medicines Growth Rate (2017-2019)
Figure Southeast Asia Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Occupational Medicines Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Occupational Medicines Growth Rate (2017-2019)
Figure South America Occupational Medicines Revenue and Growth Rate (2017-2019)
Figure South America Occupational Medicines by Countries (2017-2019)
Figure South America Occupational Medicines Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Occupational Medicines Growth Rate (2017-2019)
Figure Brazil Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Occupational Medicines Growth Rate (2017-2019)
Figure Argentina Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Occupational Medicines Growth Rate (2017-2019)
Figure Columbia Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Occupational Medicines Growth Rate (2017-2019)
Figure Rest of South America Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Occupational Medicines Growth Rate (2017-2019)
Figure Middle East and Africa Occupational Medicines Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Occupational Medicines by Countries (2017-2019)
Figure Middle East and Africa Occupational Medicines Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Occupational Medicines Growth Rate (2017-2019)
Figure Saudi Arabia Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Occupational Medicines Growth Rate (2017-2019)
Figure United Arab Emirates Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Occupational Medicines Growth Rate (2017-2019)
Figure Egypt Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Occupational Medicines Growth Rate (2017-2019)
Figure Nigeria Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Occupational Medicines Growth Rate (2017-2019)
Figure South Africa Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Occupational Medicines Growth Rate (2017-2019)
Figure Turkey Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Occupational Medicines Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Occupational Medicines Revenue (Millions USD) and Growth Rate (2017-2019)
Table Johnson & Johnson Occupational Medicines Financial Overview
Table Amgen Inc. Occupational Medicines Financial Overview
Table Novartis AG Occupational Medicines Financial Overview
Table AstraZeneca PLC Occupational Medicines Financial Overview
Table Sanofi Occupational Medicines Financial Overview
Table Bristol-Myers Squibb Company Occupational Medicines Financial Overview
Table Pfizer Inc. Occupational Medicines Financial Overview
Table Eli Lilly and Company Occupational Medicines Financial Overview
Table Nestlé S.A. (Galderma S.A.) Occupational Medicines Financial Overview
Table F. Hoffmann-La Roche Ltd. Occupational Medicines Financial Overview
Figure Global Occupational Medicines Revenue (Millions USD) and Growth Rate (2019-2027)
Table Occupational Medicines Market Forecast by Regions (2019-2027)
Figure North America Occupational Medicines Market Forecast (2019-2027)
Figure United States Occupational Medicines Market Forecast (2019-2027)
Figure Canada Occupational Medicines Market Forecast (2019-2027)
Figure Mexico Occupational Medicines Market Forecast (2019-2027)
Figure Europe Occupational Medicines Market Forecast (2019-2027)
Figure Germany Occupational Medicines Market Forecast (2019-2027)
Figure France Occupational Medicines Market Forecast (2019-2027)
Figure UK Occupational Medicines Market Forecast (2019-2027)
Figure Russia Occupational Medicines Market Forecast (2019-2027)
Figure Italy Occupational Medicines Market Forecast (2019-2027)
Figure Rest of Europe Occupational Medicines Market Forecast (2019-2027)
Figure Asia-Pacific Occupational Medicines Market Forecast (2019-2027)
Figure China Occupational Medicines Market Forecast (2019-2027)
Figure Japan Occupational Medicines Market Forecast (2019-2027)
Figure Korea Occupational Medicines Market Forecast (2019-2027)
Figure India Occupational Medicines Market Forecast (2019-2027)
Figure Southeast Asia Occupational Medicines Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Occupational Medicines Market Forecast (2019-2027)
Figure South America Occupational Medicines Market Forecast (2019-2027)
Figure Brazil Occupational Medicines Market Forecast (2019-2027)
Figure Argentina Occupational Medicines Market Forecast (2019-2027)
Figure Columbia Occupational Medicines Market Forecast (2019-2027)
Figure Rest of South America Occupational Medicines Market Forecast (2019-2027)
Figure Middle East and Africa Occupational Medicines Market Forecast (2019-2027)
Figure Saudi Arabia Occupational Medicines Market Forecast (2019-2027)
Figure United Arab Emirates Occupational Medicines Market Forecast (2019-2027)
Figure Egypt Occupational Medicines Market Forecast (2019-2027)
Figure Nigeria Occupational Medicines Market Forecast (2019-2027)
Figure South Africa Occupational Medicines Market Forecast (2019-2027)
Figure Turkey Occupational Medicines Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Occupational Medicines Market Forecast (2019-2027)
Figure Global Occupational Medicines Forecast by Application (2019-2027)
Figure Global Occupational Medicines Market Share Forecast by Application (2019-2027)
Figure Global Occupational Medicines Forecast by Application (2019-2027)
Figure Global Occupational Medicines Forecast by End User (2019-2027)
Figure Global Occupational Medicines Market Share Forecast by End User (2019-2027)
Figure Global Occupational Medicines Forecast by End User (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|